Egyptian pharmaceutical company produces anti-cancer drugs in Kazakhstan


The Egyptian company Eipico intends to build a full-cycle biopharmaceutical plant in the Karaganda region worth $30 million, Kazakh Invest reports.

The plant in Saran plans to produce biosimilars and anticancer drugs that will meet international GMP standards. Drugs for the treatment of oncological diseases will be supplied to the domestic...